DSpace Repository

PATIENTS RECEIVING HEMODIALYSIS DO NOT LOSE SARS-COV-2 ANTIBODIES MORE RAPIDLY THAN NON-RENAL CONTROLS: A PROSPECTIVE COHORT STUDY

Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States

Video Guide

Submission guideSubmission guide

Submit your materials for publication to

NU Repository Drive

Browse

My Account

Statistics